| Sl No. | Title of the Project | Principal Investigator | Funding Agency | Department | Santioned Amount | Duration |
| 1 | Structure-guided Design of New Antibacterial Agents against Dormant Mycobacterium Tuberculosis | Dr.D.Sriram | DBT (Indo-Sweden) | Pharmacy | 9688000 | 2010-2014 |
| 2 | Development of novel antitubercular drugs ASTRA ZENECA | Dr.D.Sriram | ASTRA ZENECA | Pharmacy | 1111111 | 2010-2013 |
| 3 | Structure based rational design and synthesis of mycobacterium tuberculosis pantothenate synthetase inhibitors | Dr.D.Sriram | DST-SERC | Pharmacy | 2380000 | 2010-2013 |
| 4 | Development of Novel DNA Gyrase Inhibitors Against Mycobacterium tuberculosis and other Non-tubercular Mycobacterial Infections | Dr.D.Sriram | CSIR | Pharmacy | 1676000 | 2010-2013 |
| 5 | Development, synthesis and testing of novel HIV drugs | Dr. D. Sriram | DST-IBSA | Pharmacy | 3184500 | 2011-2014 |
| 6 | Development of Newer Isoniazid Derivatives for the Treatment of Tuberculosis and Multi-drug Resistant Tuberculosis | Dr. D. Sriram | ICMR | Pharmacy | 1712474 | 2011-2014 |
| 7 | Drug discovery of inhibitors of the Protease of Peripheral Macrophages and Microglial cells in spinal cord for the treatment of neuropathic pain | Dr.P.Yogeeswari | DST | Pharmacy | 3978300 | 2012-2015 |
| 8 | Discovery of Novel Modulators of NAD(+) Dependent Protein Deacetylase SIRT 1 for the treatment of Various Human Disorders | Dr.P.Yogeeswari | DBT (Sirt) | Pharmacy | 2977000 | 2011-2014 |
| 9 | Structure-guided design of novel non-peptidic noncovalent selective inhibitors of the spinal micgorglial cathepsins for the treatment of neuropathic pain | Dr. Yogeeswari | DBT(Neuro) | Pharmacy | 3112000 | 2011-2013 |
| 10 | Design, Characterization and Pharmacokinetic Evaluation of Nanocarriers for Antiretroviral Drug Delivery in the Effective Treatment of HIV/AIDS | Dr Punna Rao R | DST FT | Pharmacy | 2310000 | 2012-2015 |
| 11 | Quality Control studies and standardization of safflower petals of different Indian cultivars as per World Health Organisation (WHO) requirement | Dr. Sajeli Begum | UGC | Pharmacy | 944800 | 2011-2014 |
| 12 | Design, pharmacokinetic and pharmacodynamic evaluation of nanocarriers for selective estrogen receptor modulators (SERMs) delivery in the effective treatment of post-menopausal osteoporosis. | Dr.Punna Rao | UGC | Pharmacy | 783000 | 2011-2014 |
| 13 | Design and synthesis of pharmacophoric hybrids as potential leads for the treatment of neuropathic pain | Dr.P.Yogeeswari | CSIR | Pharmacy | 2028000 | 2012-2015 |
| 14 | Development of Novel anti-inflammatory agents, Incozen Therapeutics Ltd., Hyderabad. | Dr. P. Yogeeswari | IncozeN | Pharmacy | 2100000 | 2012-2015 |
| 15 | Transcutaneous delivery of macromolecules using layer-by-layer asembl;y to treat skin conditions | Dr. Vamsi Krishna Venuganti | DST FT | Pharmacy | 2300000 | 2012-2015 |
| 16 | Structure Based Rational Design and Synthesis of Inhibitors for Various Enzymes of Mycobacterium tuberculosis | Dr.D.Sriram | ABG | Pharmacy | 1800000 | 2011-2013 |
| 17 | Development of new antiepileptic leads to suppress hippocampal leads to suppress hippocampal epileptic seizures | Dr P Yogeeswari | DST-INDO-UKARINE | Pharmacy | 774000 | 2012-2015 |
| 18 | Investigation of Natural Coumarinolignans and Their Newer Synthetic Analogs as Cyclooxygenase (COX-2) and Tumor necrosis factor (TNF-a) inhibitory agents in Rheumatoid Arthritis | Dr.Sajeli Begum | CSIR | Pharmacy | 2102000 | 2012-2015 |
| 19 | Non -Invasive Delivery od siRNA to treat Melanoma | Dr. VVS Vamsi Krsishna | DBT (RGYI) | Pharmacy | 3119000 | |
| 20 | Development and analysis of novel inhibitors against M. tuberculosis GImU. | Dr. D. Sriram | CSIR-OSDD | Pharmacy | 3956820 | 2012-2015 |
| 21 | STRUCTURE BASED RATIONAL DESIGN AND SYNTHESIS OF INHIBITORS FOR VARIOUS ENZYMES OF HIV | Dr. Sriram | DBT | Pharmacy | 5617400 | 2012-2015 |
| 22 | Fund for the improvement of S&T infrastructure in higher educational institutions (Department of Pharmacy) | | DST FIST | Pharmacy | 3000000 | |